Funded Tech Companies

Tokai Pharmaceuticals

Operating out of Boston, Tokai Pharmaceuticals has funding from Novartis Venture Fund, private investors and Apple Tree Partners.

Company Overview

Company Name
Tokai Pharmaceuticals
Company Status
Publicly-held
Funding Rounds

Contact Information

Mailing Address
255 State St. 6th floor
Boston, MA 02109
USA
Email Address
Not Recorded

Company Background Information

Overview
Tokai Pharmaceuticals (NASDAQ: TKAI) develops biopharmaceutical products that focus on endocrine treatment. The company is developing novel, proprietary therapies for prostate cancer and other hormonally-driven diseases.
Profile
Tokai Pharmaceuticals  LinkedIn Company Profile
Social Media
Tokai Pharmaceuticals  Company Twitter Account
Company News
Tokai Pharmaceuticals  News
Facebook
Tokai Pharmaceuticals  on Facebook
YouTube
Tokai Pharmaceuticals  on YouTube
Last Transaction
9/17/2014

Financing History

Date
Type
Amount
IPO
$97,500,000
Venture Equity
$35,500,000
Venture Equity
$23,000,000
Venture Equity
$22,000,000
Venture Equity
$9,264,900


Management Team

Title
Name
Email & Social
Chief Executive Officer
Jodie Morrison
  Jodie Morrison LinkedIn Profile  Jodie Morrison Twitter Account  Jodie Morrison News  Jodie Morrison on Facebook
Chief Operating Officer
John McBride
  John McBride LinkedIn Profile  John McBride Twitter Account  John McBride News  John McBride on Facebook


Company Investors

  • Novartis Venture Fund (Reinhard Ambros)
  • Apple Tree Partners (Seth Harrison)
  • Queensland Investment Corporation

 

 

 

Browse more funded tech companies:

TOK.tv | TokBox

 

Share this article

 


About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary